Citius Pharmaceuticals
CTXR
#10616
Rank
NZ$26.51 M
Marketcap
NZ$0.97
Share price
3.08%
Change (1 day)
-59.99%
Change (1 year)

Earnings for Citius Pharmaceuticals (CTXR)

Earnings in 2026 (TTM): -NZ$94.31 Million

According to Citius Pharmaceuticals 's latest financial reports the company's current earnings are NZ$5.61 Million. In 2025 the company made an earning of -NZ$64.93 Million, an increase over its 2024 earnings that were of -NZ$68.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Citius Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$94.31 Million45.26%
2025 -NZ$64.93 Million-4.99%
2024 -NZ$68.33 Million5.78%
2023 -NZ$64.6 Million37.8%
2022 -NZ$46.88 Million13.08%
2021 -NZ$41.46 Million12.91%
2020 -NZ$36.72 Million33.5%
2019 -NZ$27.51 Million21.61%
2018 -NZ$22.62 Million14.93%
2017 -NZ$19.68 Million23.83%
2016 -NZ$15.9 Million180.39%
2015 -NZ$5.67 Million
2013 -NZ$0.97 Million2605.74%
2012 -NZ$0.04 Million4.81%
2011 -NZ$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion 173.10%๐Ÿ‡บ๐Ÿ‡ธ USA